NCT05809258

Brief Summary

This study compares the analgesic efficacy of supraclavicular brachial plexus nerve block to axillary nerve block techniques in adults undergoing AV fistula creation. Both these techniques will be done under ultrasound guidance, using the same local anesthetic drug. 120 patients will be included in this study, 60 patients for each technique. This study will help us know better regional anesthesia techniques, the additional need for analgesia/anesthesia, and the recovery rate following either of the blocks for AV fistula surgery. An interim analysis will be done after recruiting 50% of cases (30 cases) in both arms.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 12, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

August 7, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

November 22, 2023

Status Verified

November 1, 2023

Enrollment Period

1.3 years

First QC Date

February 22, 2023

Last Update Submit

November 20, 2023

Conditions

Keywords

Arteriovenous fistulabrachial plexus blockultrasound guidedcomplicationsblock recovery

Outcome Measures

Primary Outcomes (1)

  • Requirement of additional analgesics intraoperatively or block failure (conversion to general anaesthesia)

    Paracetamol 15 mg/kg or Fentanyl 0.5 mics/kg or local infiltration or change to General Anesthesia

    20 minutes to 2 hours 30 minutes

Secondary Outcomes (2)

  • Time of motor recovery of block

    up to 24 hours

  • Rate of complications

    up to 24 hours

Other Outcomes (1)

  • Brachial artery diameter

    0 to 3 hours

Study Arms (2)

Supraclavicular block

ACTIVE COMPARATOR

In the supraclavicular group, the ultrasound probe will be positioned in the supraclavicular fossa, pointing caudad and locating the subclavian artery. The first rib is identified deep to the artery, and the hyperechoic pleura will be identified by sliding lung sign. The brachial plexus is consistently found with a characteristic ''honeycomb'' appearance lateral and superficial to the subclavian artery and superior to the first rib. The needle will be introduced through the skin from lateral to medial, in-plane with the transducer, with constant visualization, and directed toward the deep border of the nerve group. Three separate injections will be made at various sites in the bundle, tending to start deep, in the ''corner pocket'' close to the artery, and moving more superficially. The local anesthetics will be Lidocaine 2% 10 ml + Levobupivacaine 0.5% 10 ml.

Procedure: Supraclavicular block

Axillary block

ACTIVE COMPARATOR

Patients in the axillary group are placed in the supine position with the arm to be blocked, abducted and externally rotated. After sterilization of the axilla, the Ultrasound probe will be placed parallel to the anterior axillary fold at the axilla to identify the axillary artery and surrounding radial, ulnar, and median nerve, appearing as hypo-echoic round structures around the axillary artery. The musculocutaneous nerve will also be identified between the coracobrachialis and biceps muscle or in either of them. Lidocaine 1% was infiltrated subcutaneously 1 cm lateral to the probe, and then 0.5% bupivacaine will be injected around branches of the brachial plexus. The local anesthetics will be Lidocaine 2% 10 ml + Levobupivacaine 0.5% 15 ml. In this block, 5-7 ml of local anesthetic will block each nerve.

Procedure: Axillary block

Interventions

brachial plexus nerve block by supraclavicular route

Also known as: brachial plexus block
Supraclavicular block

brachial plexus nerve block by axillary route

Also known as: brachial plexus block
Axillary block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years old
  • Patients undergoing AV fistula creation in the antecubital fossa

You may not qualify if:

  • \- Patient Refusal
  • Hemodynamically unstable patient
  • Local infection over the insertion site
  • Coagulopathy
  • Known allergy to Local Anaesthetic medications
  • Abnormal anatomy
  • Use of antiplatelet within 7 days of surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sultan Qaboos University Hospital

Muscat, 123, Oman

RECRUITING

Related Links

MeSH Terms

Conditions

Arteriovenous Fistula

Interventions

Brachial Plexus Block

Condition Hierarchy (Ancestors)

Arteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nerve BlockAnesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Jyoti Burad, MD, EDIC

    Sultan Qaboos University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jyoti Burad, MD, EDIC

CONTACT

Yousef Emam Abouelatta, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The investigator and assessor will be blinded. The block performer anaesthetist and the patient will know the technique.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two parallel arms of interventions, no crossover.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior specialist

Study Record Dates

First Submitted

February 22, 2023

First Posted

April 12, 2023

Study Start

August 7, 2023

Primary Completion

December 1, 2024

Study Completion

May 1, 2025

Last Updated

November 22, 2023

Record last verified: 2023-11

Locations